mdBriefCase names Jason Flowerday as CEO

mdBriefCase, a leading provider of online continuing professional development for physicians, pharmacists, nurses, and other allied healthcare professionals, appointed Jason Flowerday as CEO.

Mr. Flowerday brings more than two decades of industry experience focusing on operations management, business development, and strategy.

Before joining mdBriefCase, he held CEO positions at 3D Signatures, a personalized medical software company; Pro Bono Bio, a UK biotechnology and medical device company; and Knight Therapeutics.

In addition, he spent more than a decade at Bayer Healthcare and Ortho Biotech before co-founding and selling a pair of successful start-ups, which included a digital healthcare medical education company.

“With a proven track record created over the past 17 years, and more than 170,000 members worldwide, mdBriefCase is in a great position to deliver new and exciting continuing medical education to improve patient care on a global scale,” he said in a statement.

John Trang, a partner at Persistence Capital Partners, private equity partners of mdBriefCase, said “we are fully committed to supporting mdBriefCase as the company continues its global expansion strategy.”

Internationally, mdBriefCase has expanded to deliver learning content for healthcare professionals in 16 countries around the world. In Canada, the company has more than 20 long-standing partnerships, including recently formed collaborations between the Royal College of Physicians and Surgeons of Canada, the Canadian Nurses Association, the Canadian Thoracic Society, and the Canadian Society of Endocrinology and Metabolism.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.